Serpentine supravenous hyperpigmentation in an HIV patient receiving R-CHOP for DLBCL

Guido Lancman, Amir Steinberg, Janice Gabrilove

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU1-3, but also seen with docetaxel4,5, fotemustine6, and vinorelbine7. It consists of a marked hyperpigmentation along the superficial network of veins proximal to the chemotherapy infusion site and was originally described in a 1976 case report in association with 5-FU1. Here, for the first time, we report SSH in association with R-CHOP chemotherapy.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalInternational Journal of Hematology-Oncology and Stem Cell Research
Volume12
Issue number1
StatePublished - 2018

Keywords

  • Chemotherapy
  • DLBCL
  • R- CHOP
  • SSH
  • Serpentine supravenous hyperpigmentation

Fingerprint

Dive into the research topics of 'Serpentine supravenous hyperpigmentation in an HIV patient receiving R-CHOP for DLBCL'. Together they form a unique fingerprint.

Cite this